The abrogation of IDH2 by shRNA or by chemical inhibitor in TNBC cells led to a significant increase in cellular α-KG, a decrease of HIF1α, and a major suppression of tumor cell growth both in vitro and in vivo, indicating an important role of IDH2 in supporting TNBC metabolism and cell proliferation. The gene discussed is IDH2; the disease is neoplasm.